title: Absence of protective effect of renin-angiotensin system inhibitors on atrial fibrillation development: insights from the Canadian Trial of Atrial Fibrillation (CTAF).
abstract: BACKGROUND
  Antiarrhythmic agents have modest efficacy in preventing atrial fibrillation (AF) recurrence. Although retrospective analyses have suggested a preventive effect of inhibitors of the renin-angiotensin system (RAS) on AF development in patients with congestive heart failure or hypertension, the value of these agents has not been evaluated in patients with AF but without a high prevalence of hypertension or heart failure.
  
  
  RESULTS
  A retrospective analysis of the Canadian Trial of Atrial Fibrillation (CTAF) was conducted. CTAF demonstrated the superiority of amiodarone (A) over sotalol or propafenone (SP) in maintaining sinus rhythm in patients with AF. Of the 403 patients randomly assigned in CTAF, 11.7% of the A group and 12.7% of the SP group were receiving a RAS inhibitor at baseline. By multivariate analysis (including all the risk factors known to be associated with AF available in the database), the use of RAS blockers in addition to antiarrhythmic agents was not associated with additional benefit against AF development. There was a recurrence of AF in 59 patients (38.3%) and 14 patients (29.8%) of groups A and A-RAS, respectively, while 93 patients (61.6%) and 32 patients (62.8%) of the SP and SP-RAS groups, respectively, experienced recurrent AF.
  
  
  CONCLUSIONS
  Blocking the RAS did not provide additional benefit against AF recurrence in CTAF patients treated with an antiarrhythmic drug. These results underscore the need for randomized clinical trials to clearly define the role of RAS inhibitors in treating AF.
authors.affiliation: Department of Medicine, Montreal Heart Institute, Montreal, Canada.
authors.forename: Maryse
authors.initials: M
authors.lastname: Palardy
authors.forename: Anique
authors.initials: A
authors.lastname: Ducharme
authors.forename: Stanley
authors.initials: S
authors.lastname: Nattel
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Tardif
authors.forename: Michel
authors.initials: M
authors.lastname: White
authors.forename: Normand
authors.initials: N
authors.lastname: Racine
authors.forename: Karine
authors.initials: K
authors.lastname: Tétreault
authors.forename: Farida
authors.initials: F
authors.lastname: Dabouz
authors.forename: Mario
authors.initials: M
authors.lastname: Talajic
authors.forename: Denis
authors.initials: D
authors.lastname: Roy
mesh_terms: D000368:Aged; D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D002170:Canada; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011405:Propafenone / Q000627:therapeutic use; D011446:Prospective Studies; D012084:Renin-Angiotensin System / Q000187:drug effects*; D055502:Secondary Prevention; D013015:Sotalol / Q000627:therapeutic use; D000092502:Renin Inhibitors
chemical_list: D000638:Amiodarone; D000889:Anti-Arrhythmia Agents; D011405:Propafenone; D013015:Sotalol; D000092502:Renin Inhibitors
references.citation: Circulation. 1999 Jul 6;100(1):87-95
references.pmid: 10393686
references.citation: Int J Cardiol. 2005 Dec 7;105(3):315-8
references.pmid: 16274775
references.citation: Eur Heart J. 2006 Aug;27(15):1841-6
references.pmid: 16825288
references.citation: JAMA. 1994 Mar 16;271(11):840-4
references.pmid: 8114238
references.citation: Can J Cardiol. 2004 Oct;20(12):1245-8
references.pmid: 15494777
references.citation: J Am Coll Cardiol. 2000 May;35(6):1669-77
references.pmid: 10807475
references.citation: Cardiovasc Res. 1999 Oct;44(1):121-31
references.pmid: 10615396
references.citation: Circulation. 1996 Dec 1;94(11):2968-74
references.pmid: 8941128
references.citation: J Am Coll Cardiol. 2005 Jun 7;45(11):1832-9
references.pmid: 15936615
references.citation: Circulation. 1997 Nov 18;96(10):3710-20
references.pmid: 9396475
references.citation: J Am Coll Cardiol. 2003 Jun 18;41(12):2197-204
references.pmid: 12821247
references.citation: J Pharmacol Toxicol Methods. 1999 Sep;42(1):11-20
references.pmid: 10715599
references.citation: Am Heart J. 2006 Jul;152(1):86-92
references.pmid: 16838426
references.citation: Heart Rhythm. 2004 Nov;1(5):531-7
references.pmid: 15851214
references.citation: Am Heart J. 2005 Mar;149(3):548-57
references.pmid: 15864246
references.citation: N Engl J Med. 2000 Mar 30;342(13):913-20
references.pmid: 10738049
references.citation: Circ Res. 1997 Oct;81(4):512-25
references.pmid: 9314832
references.citation: J Am Coll Cardiol. 2005 Mar 1;45(5):712-9
references.pmid: 15734615
references.citation: Circulation. 2003 Jun 17;107(23):2926-31
references.pmid: 12771010
references.citation: Circulation. 1996 Oct 1;94(7):1600-6
references.pmid: 8840850
references.citation: Circulation. 2001 Nov 20;104(21):2608-14
references.pmid: 11714658
references.citation: Circulation. 1997 Aug 19;96(4):1180-4
references.pmid: 9286947
references.citation: Circulation. 2000 Jun 6;101(22):2612-7
references.pmid: 10840013
references.citation: Circulation. 1997 Oct 7;96(7):2455-61
references.pmid: 9337224
references.citation: Circulation. 2002 Jul 16;106(3):331-6
references.pmid: 12119249
references.citation: Circ Res. 1997 Dec;81(6):1045-52
references.pmid: 9400386
references.citation: Am J Cardiol. 2001 Oct 15;88(8):906-9, A8
references.pmid: 11676961
references.citation: Circulation. 2004 Aug 31;110(9):1042-6
references.pmid: 15313941
references.citation: Pacing Clin Electrophysiol. 2004 Oct;27(10):1405-10
references.pmid: 15511250
references.citation: Cardiovasc Res. 2002 May;54(2):230-46
references.pmid: 12062329
references.citation: Am J Cardiol. 1991 Aug 1;68(4):335-41
references.pmid: 1907089
references.citation: Circulation. 1995 Mar 1;91(5):1588-95
references.pmid: 7867201
references.citation: Circulation. 1999 Jul 27;100(4):376-80
references.pmid: 10421597
references.citation: Heart Rhythm. 2004 Dec;1(6):669-75
references.pmid: 15851238
references.citation: Circulation. 1995 Oct 1;92(7):1954-68
references.pmid: 7671380